The 30-day risk of a hospital visit for acute respiratory failure was higher among healthy adolescents and young adults ...
AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...
As the Government gears up to consult on firmer rules around cosmetic treatments, one writer investigates the safety of ...